Hostname: page-component-6766d58669-rxg44 Total loading time: 0 Render date: 2026-05-20T01:24:19.719Z Has data issue: false hasContentIssue false
  • English
  • Français

Familial carotid body tumours: is there a role for genetic screening?

Published online by Cambridge University Press:  19 July 2007

P Jani ,
A A Qureshi ,
S Verma  and
L Walker
P Jani
Affiliation:
Departments of Otolaryngology and Medical Genetics, Addenbrooke's Hospital, Cambridge, UK
A A Qureshi*
Affiliation:
Departments of Otolaryngology and Medical Genetics, Addenbrooke's Hospital, Cambridge, UK
S Verma
Affiliation:
Departments of Otolaryngology and Medical Genetics, Addenbrooke's Hospital, Cambridge, UK
L Walker
Affiliation:
Departments of Otolaryngology and Medical Genetics, Addenbrooke's Hospital, Cambridge, UK
*
Address for correspondence: Mr A Qureshi, Clinic 10, Box 48, Department of Otolaryngology, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK. Fax: 01223 217559 E-mail: aa_qur@yahoo.co.uk
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

Carotid body tumours are rare lesions which are familial in 10 per cent of cases. In this paper, we demonstrate the clinical applicability of predictive genetic testing for familial carotid body tumours.

Methods:

We report a case manifesting with multiple carotid body tumours, in which subsequent genetic testing demonstrated a germline mutation which could be traced across generations. We review the diagnosis and management of carotid body tumours in the familial setting, together with the strategies presently available to screen individuals from susceptible families.

Conclusions:

The recent advent of a predictive genetic test for familial carotid body tumours offers a novel means of pre-selecting those at risk, so as to minimise screening costs and patient morbidity. Early diagnosis of lesions is essential to allow early intervention, reducing surgical morbidity and progression to malignancy.

Keywords

Carotid Body TumoursParagangliomasScreening

Information

Type
Clinical Record
Information
The Journal of Laryngology & Otology , Volume 122 , Issue 9 , September 2008 , pp. 978 - 982
Copyright
Copyright © JLO (1984) Limited 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1 Chase, WH. Familial and bilateral tumours of the carotid body. J Pathol Bacteriol 1933;36:1–12CrossRefGoogle Scholar
2 Grufferman, S, Gillman, MW, Pasternak, LR, Peterson, CL, Young, WG Jr. Familial carotid body tumours: case report and epidemiologic review. Cancer 1980;46:2116–223.0.CO;2-S>CrossRefGoogle ScholarPubMed
3 Heutink, P, van der Mey, AG, Sandkuijl, LA, van Gils, AP, Bardoel, A, Breedveld, GJ et al. A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum Mol Genet 1992;1:7–10CrossRefGoogle ScholarPubMed
4 Hamilton, JRL, Barros D'Sa, AAB. Radionuclide angiography and surgery for familial bilateral chemodectomas. Eur J Vasc Surg 1987;1:97–104CrossRefGoogle ScholarPubMed
5 Benn, DE, Gimenez-Roqueplo, AP, Reilly, JR, Bertherat, J, Burgess, J, Byth, K et al. Clinical presentation and penetrance of phaeochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 2006;91:827–36CrossRefGoogle ScholarPubMed
6 Pellitteri, PK, Rinaldo, A, Myssiorek, D, Gary Jackson, C, Bradley, PJ, Devaney, KO et al. Paragangliomas of the head and neck. Oral Oncol 2004;40:563–75CrossRefGoogle ScholarPubMed
7 Koch, CA, Vortmeyer, AO, Zhuang, Z, Brouwers, FM, Pacak, K. New insights into the genetics of familial chromaffin cell tumours. Ann N Y Acad Sci 2002;970:11–28CrossRefGoogle Scholar
8 Young, WF Jr. Paragangliomas: clinical overview. Ann N Y Acad Sci 2006;1073:21–9CrossRefGoogle ScholarPubMed
9 Astuti, D, Latif, F, Dallol, A, Dahia, PL, Douglas, F, George, E et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial phaechromocytoma and to familial paraganglioma. Am J Hum Genet 2001;69:49–54CrossRefGoogle Scholar
10 Suárez, C, Rodrigo, JP, Ferlito, A, Cabanillas, R, Shaha, AR, Rinaldo, A. Tumours of familial origin in the head and neck. Oral Oncol 2006;42:965–78CrossRefGoogle ScholarPubMed
11 Schiavi, F, Boedeker, CC, Bausch, B, Peczkowska, M, Gomez, CF, Strassburg, T et al. Predictors and prevalence of paraganglioma syndrome associated with the mutations of the SDHC gene. JAMA 2005;294:2057–63CrossRefGoogle ScholarPubMed
12 Knight, TT, Gonzalez, JA, Rary, JM, Rush, DS. Current concepts for the surgical management of carotid body tumor. Am J Surg 2006;19:104–10CrossRefGoogle Scholar
13 Rosen, IB, Palmer, JA, Goldberg, M, Mustard, RA. Vascular problems associated with carotid body tumors. Am J Surg 1981;142:459–63CrossRefGoogle ScholarPubMed
14 van den Berg, R. Imaging and management of head and neck paragangliomas. Eur Radiol 2005;15:1310–8CrossRefGoogle ScholarPubMed
15 van den Berg, R, Wasser, MN, van Gils, AP, van der Mey, AG, Hermans, J, van Buchem, MA. Vascularization of head and neck paragangliomas: comparison of three MR angiographic techniques with digital subtraction angiography. AJNR Am J Neuroradiol 2000;21:162–70Google ScholarPubMed
16 Worsey, MJ, Laborde, AL, Bower, T, Miller, E, Kresowik, TF, Sharp, WJ et al. An evaluation of color duplex scanning in the primary diagnosis and management of carotid body tumors. Ann Vasc Surg 1992;6:90–4CrossRefGoogle ScholarPubMed
17 Kohn, JS, Raftery, KB, Jewell, ER. Familial carotid body tumors: a closer look. J Vasc Surg 1999;29:649–53CrossRefGoogle ScholarPubMed
18 McCaffrey, TV, Meyer, FB, Michels, VV, Piepgras, DG, Marion, MS. Familial paragangliomas of the head and neck. Arch Otolaryngol Head Neck Surg 1994;120:1211–6CrossRefGoogle ScholarPubMed
19 Van Gils, AP, van Erkel, AR, Falke, TH, Pauwels, EK. Magnetic resonace imaging or metaiodobenzylguanidine scintigraphy for the demonstration of paragangliomas? Correlations and disparities. Eur J Nucl Med 1994;21:239–53CrossRefGoogle ScholarPubMed
20 Myssiorek, D, Palestro, CJ. 111indium pentetreotide scan detection of familial paragangliomas. Laryngoscope 1998;108:228–31CrossRefGoogle ScholarPubMed
21 Hoegerle, S, Ghanem, N, Altehoefer, C, Schipper, J, Brink, I, Moser, E et al. 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging 2003;30:689–94CrossRefGoogle ScholarPubMed
22 Alkadhi, H, Schuknecht, B, Stoeckli, SJ, Valavanis, A. Evaluation of topography and vascularization of cervical paragangliomas by magnetic resonance imaging and color duplex sonography. Neuroradiology 2002;44:83–90CrossRefGoogle ScholarPubMed
23 Baysal, BE, Ferrell, RE, Willett-Brozick, JE, Lawrence, EC, Myssiorek, D, Bosch, A et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000;287:848–51CrossRefGoogle ScholarPubMed
24 Astuti, D, Douglas, F, Lennard, TW, Aligianis, IA, Woodward, ER, Evans, DG et al. Germline SDHD mutation in familial phaeochromocytoma. Lancet 2001;357:1181–2CrossRefGoogle ScholarPubMed
25 Ogawa, K, Shiga, K, Saijo, S, Ogawa, T, Kimura, N, Horii, A. A novel G106D alteration of the SDHD gene in a pedigree with familial paraganglioma. Am J Med Genet A 2006;140:2441–6CrossRefGoogle Scholar